Investment Committee Summary
| Rating | BUY |
| Internal 5-tier | STRONG BUY |
| Classification · conviction | mature cash generator · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | $195 (+7% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $249 (+37% vs spot · 12m PWEV) |
| Next catalyst | 2026-10-15 — US BIS export-control rule update on advanced-node tools to China |
| Primary thesis-break | Quarterly revenue year-on-year growth < -0.05 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: BUY
Internal 5-tier: STRONG BUY · mature cash generator · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $182 |
| Triangulated Fair Value | $195 (+7% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $249 (+37% vs spot · 12m PWEV) |
| Forward P/E | 37.1x |
| Market Cap | $248B |
| 52-Week Range | $82.87–$301 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across three weighted anchors — an intrinsic DCF, a scenario-weighted PWEV and a Monte Carlo median (Student-t + regime switching). Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 81.6/100 (100th pct) | +37% 1yr expected | Increase | Call Debit Spread | 51d — US BIS export-control rule update on advanced-node tools to China |
Research rating: BUY · Tactical / decision-rule stance: Increase — the stance is the machine decision-rules layer (hysteresis, kill-switches, freshness); the rating is the valuation verdict. They may diverge and are reconciled in the Decision Rules section below.
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: BUY
Balanced: triangulated fair value $195 (+7% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At $182 on 25 August 2026 KLA trades near 37x forward earnings after a substantial drawdown from its 52-week high, so the price now embeds real doubt about how much of the recent wafer-fabrication-equipment spending is durable. The engine sees the franchise as genuinely advantaged: process control is the highest-margin niche in semiconductor capital equipment, and the segment operating margin near 55% is the evidence. Triangulated fair value is $195, +7% against spot, so the shares are fairly valued against the blended evidence, while the probability-weighted value of $249 and the 12-month target of $250 reflect a base path of normalised equipment spending worth more than the tape is currently paying. The rating is BUY, and the honest qualification is that most of the modelled dispersion comes from the multiple rather than revenue: the outcome depends on what the market will pay for cyclical earnings, not on whether those earnings appear. The bear side is not decorative either, since the cyclical capital-cut path sits close to today's price. The single most damaging risk is a synchronised de-rating and order air-pocket, in which a compressing multiple meets falling revenue at the same time, on a balance sheet carrying net debt of ~$4.4B, and the structural reset-and-export-control path targets a price below the 52-week low.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($182) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The steelman for the bear runs through order timing, not franchise quality. Process control is genuinely advantaged, but KLA still sells capital equipment out of a cyclical fabrication budget that customers cut first when utilisation falls. A digestion phase after two years of heavy AI-driven capacity spending, layered on tighter export controls that remove a chunk of addressable demand, produces the capital-cut mechanism: bookings roll below parity, revenue contracts at a low-double-digit rate, and fixed-cost deleverage takes the operating margin several points beneath 55%. At 37x forward earnings even a modest miss is amplified by multiple compression, because the rating prices permanence into an inherently cyclical order book. The result is a price nearer the cyclical or structural paths than the base, and the structural path, which combines an equipment reset with export restriction, targets a price below the 52-week low.
Key Debate
P/E Multiple explains 82% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 33.3× consensus forward EPS, vs the house DCF terminal 30.0×, and a peer median 47.6×. The house DCF sits 21% below spot, so the market is pricing in more than the house case — roughly 2.3pp of revenue CAGR.
Variant perception: the house view is above-consensus, and the thesis is primarily FCF-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 18.1 | 14.1 | High |
| EPS | 5.4 | 4.9 | Medium |
| Target price | 231.8 | 249.9 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — WFE Reset / China Restriction' downside ($70.00) to a 'Bull — Supercycle Re-Rate' bull case ($457); the probability-weighted blend (PWEV $249) is +37% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — WFE Reset / China Restriction | 20% | $70.00 | -61% |
| Cyclical Downturn — Capex Cut | 17% | $189 | +4% |
| Base — Normalised WFE | 35% | $268 | +48% |
| Upcycle — Leading-Edge / HBM Capex | 20% | $362 | +100% |
| Bull — Supercycle Re-Rate | 8% | $457 | +152% |
| Probability-Weighted (PWEV) | — | $249 | +37% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 2.4% of revenue; free cash flow net of SBC is $3.46B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — WFE Reset / China Restriction (20%, $70.00). Structural impairment — WFE reset / China restriction: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Cyclical Downturn — Capex Cut (17%, $189). Cyclical downturn — wafer-fab-equipment (WFE) spending + leading-edge / HBM capex + China restrictions weakens for 1–2 years before normalising.
- Base — Normalised WFE (35%, $268). Mid-cycle — normalised wafer-fab-equipment (WFE) spending + leading-edge / HBM capex + China restrictions; disciplined capital allocation; steady returns.
- Upcycle — Leading-Edge / HBM Capex (20%, $362). Upside — leading-edge + HBM capex lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Supercycle Re-Rate (8%, $457). Upside tail — sustained tight conditions or a structural re-rate on leading-edge + HBM capex.
Valuation Triangulation
Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $224 | +24% | 20% (declared 15%) |
| Peer EV/Revenue re-rate | multiple | $151 | -17% | 0% — cross-check only |
| Scenario PWEV | multiple | $249 | +37% | 33% (declared 25%) |
| DCF (5-year + terminal) | cash flow + terminal × | $144 | -21% | 47% (declared 35%) |
| Triangulated (weighted) | — | $195 | +7% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $224 and 69% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (82% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 10.0%, 30.0x terminal FCF multiple → $144. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $151; the peer-median forward P/E is 47.6x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.
Across all anchors the spread is 47% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 21.0x | 25.5x | 30.0x | 34.5x | 39.0x |
|---|---|---|---|---|---|
| 8.0% | $116 | $137 | $157 | $178 | $198 |
| 9.0% | $111 | $131 | $150 | $170 | $189 |
| 10.0% | $106 | $125 | $144 | $162 | $181 |
| 11.0% | $102 | $120 | $138 | $156 | $173 |
| 12.0% | $97.79 | $115 | $132 | $149 | $166 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $119 | $122 | $125 | $128 | $132 |
| -1.5pp | $127 | $131 | $134 | $138 | $141 |
| +0.0pp | $137 | $140 | $144 | $147 | $151 |
| +1.5pp | $146 | $150 | $154 | $158 | $162 |
| +3.0pp | $156 | $160 | $165 | $169 | $173 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Revenue CAGR ±3pp | $125 | $165 | $39.00 |
| Terminal × ±15% | $125 | $162 | $37.00 |
| Op margin ±3pp | $137 | $151 | $15.00 |
| WACC ±1pp | $138 | $150 | $13.00 |
| Capex intensity ±15% | $143 | $145 | $3.00 |
Company lever — SoP/share vs Semiconductor Equipment multiple (AI re-rating) (base 51.0x)
| Multiple | 35.7x | 43.4x | 51.0x | 58.6x | 66.3x |
|---|---|---|---|---|---|
| SoP/share | $187 | $228 | $269 | $310 | $351 |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| LRCX | 47.6× | 8% | 35% | segment | 50% |
| AMAT | 49.3× | 8% | 32% | segment | 50% |
| Q | 40.3× | 8% | 23% | direct | 100% |
Quality-weighted forward P/E: 44.4× (simple median 47.6×). Direct peers count 100%, segment 50%, broad 25%.
Valuation-anchor screen: DCF (Gordon) (low-confidence cross-check (>50% below median)). Anchor median 184.1. Extreme/excluded anchors carry no headline weight.
Historical-range cross-check: 52-week range $82.87–$301, centre $158 (-13% vs spot); spot sits at the 45th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $195 (+7% vs spot · triangulated FV) |
| Downside to bear case (Structural — WFE Reset / China Restriction) | $70.00 (-61% vs spot · bear scenario) |
| Reward/risk ratio | 0.1× |
| Margin of safety (FV vs spot) | +7% |
| P(price > spot) — Monte Carlo | 69% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Supercycle Re-Rate): $457.
Company Overview & Business Model
KLA Corporation — TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS. KLA Corporation is a capital equipment company based in Milpitas, California. It supplies process control and yield management systems for the semiconductor industry and other related nanoelectronics industries.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Semiconductor Equipment | 100% | +8% | 55% | wafer-fab-equipment (WFE) spending + leading-edge / HBM capex + China restrictions |
Edge. Wide moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Semiconductor Equipment | $13.1B | 100% | 8% | 55% | $7.3B | 51.0x | 4% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | wafer-fab-equipment (WFE) spending + leading-edge / HBM capex + China restrictions |
| net_debt_or_cash_b | -4.36 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.04 |
| div_yield | 0.0032 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | WFE reset / China restriction |
| upside | leading-edge + HBM capex |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $1.2B — modestly levered |
| Net debt / EBITDA | 0.21x |
| Interest coverage (EBIT / interest) | 19.9x |
| Current ratio | 2.88x |
| Lease obligations | $0.3B |
| Cash & ST investments | $4.9B |
Balance-sheet data as of 2026-06-30 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $3.8B |
| Buybacks / dividends | $2.3B / $1.1B |
| Total shareholder yield | 1.3% |
| Payout as % of FCF | 88.9% |
| Reinvestment (capex / OCF) | 9.1% |
| SBC as % of FCF | 8.2% |
| Allocation stance | returns-heavy |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 28.8% |
| FCF conversion (FCF / net income) | 78.0% |
| FCF yield | 1.5% |
| Capex intensity (capex / revenue) | 2.9% |
| FCF − SBC (diagnostic) | $3.5B |
| Capex split (maint / growth) | 45% / 55% — Capex history ($0.34B) runs below the forward glidepath (~$0.38-0.54B) because the schedule ramps with the normalised-WFE revenue path - the growth slice (R&D labs, manufacturing/capacity for advanced tools) dominates. Still asset-light vs a fab: capex is only ~4% of revenue, the moat is R&D-intensive not capex-intensive. |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 86% — cash-backed.
Competitive Moat
Moat sources:
- ~50%+ share of the process-control / inspection & metrology segment - a dominant, hard-to-displace position at leading-edge nodes
- Installed-base service + software revenue that grows with tools shipped and raises switching costs (calibration, recipes, engineer familiarity)
- Deep leading-edge and advanced-packaging technology lead that widens as process complexity (EUV, gate-all-around, HBM) rises
- NO insulation from the WFE capex cycle - the moat protects share and margin, not the absolute level of demand
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q3): management +0.24 vs analyst floor +0.00 → delta +0.24 (n=35 mgmt / 25 Q&A; 17th pctile across the S&P book, z -1.1).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q3 | +0.24 | +0.00 | +0.24 |
| 2026Q2 | +0.46 | +0.25 | +0.21 |
| 2026Q1 | +0.46 | +0.12 | +0.34 |
| 2025Q4 | +0.58 | +0.51 | +0.07 |
News (last 365d, 1599 articles): avg ticker sentiment +0.16 (bullish 25% / bearish 7%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $232 (+28% vs spot · street) |
| House target | $250 (+7.8% vs street) |
| Sell-side coverage | 29 analysts (SB 5 / B 13 / H 11 / S 0 / SS 0; net score 0.4) |
| Consensus FY EPS | $5.45 (reference only — house values on EV/EBITDA) |
| Consensus FY revenue | $18.1B; house below (-22.1%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-10-15 (~52d) — US BIS export-control rule update on advanced-node tools to China (authored)
Forecast Track Record
- EPS surprise: beat 100% of the last 8 quarters; average surprise +4.1%.
- Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 8%; mean predicted +21.1% vs realised -12.0%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
5 catalysts in the next 90 days (of 13 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-15 (in 51d) | US BIS export-control rule update on advanced-node tools to China | authored | ● | 0.7 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-06-09 (in 288d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-06-18 (in 297d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| US / allied export controls on advanced semiconductor tools to China (entity list, sub-14nm rules) | high (~55%) | high - China is a high-30s-to-low-40s % revenue share; a step-tighten is a direct structural demand hit, ~8-12% of FV | 12-24m |
| Chinese retaliation / indigenous-tool substitution accelerating in mature-node process control | medium (~35%) | medium - erodes the China served market over time, ~4-6% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — WFE Reset / China Restriction | A deep WFE reset compounded by tighter China export controls that permanently remove a chunk of addressable demand | Revenue stepping down ~a third with incremental deleverage to low-40s margin while the multiple de-rates to a deep-cyclical trough - target below the 52-week low |
| Cyclical Downturn — Capex Cut | An ordinary capex-digestion air-pocket after two AI-driven years - foundry/logic and memory customers defer tool orders for 1-2 years | Bookings rolling below parity and revenue falling low-double-digits with fixed-cost deleverage giving back ~7 margin points |
| Upcycle — Leading-Edge / HBM Capex | Leading-edge and HBM/advanced-packaging capex lifts tool demand above trend with operating leverage | AI-driven leading-edge capex proving front-loaded, setting up a sharper digestion phase afterward |
| Bull — Supercycle Re-Rate | A sustained supercycle where process-control intensity rises structurally with advanced-node and advanced-packaging complexity | Peak-margin, peak-multiple economics being the most mean-reversion-prone point in a cyclical franchise |
Scenario-macro rows withheld pending re-authoring: 1 carrying another cluster's vocabulary or a frozen figure — recorded in the narrative quarantine ledger.
Decision Rules (Machine-Checked)
Stance: Increase — 1 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
37.63 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
37.63 | YES |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.4 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
85.8 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.08 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.7 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Quarterly revenue year-on-year growth < -0.05 (2 consecutive prints). Two consecutive quarters of contracting revenue would confirm the cyclical-downturn path rather than the mid-single-digit base growth, and pull the fair value toward the capex-cut scenario.
- Non-GAAP operating margin < 0.51 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- China share of total revenue > 0.42 (2 consecutive prints). Concentration above the low-40s raises the earnings at risk should export controls tighten further, mapping to the structural-restriction scenario the market is not fully discounting.
- Book-to-bill / bookings commentary direction < 1.0 (2 consecutive prints). A book-to-bill below parity for two quarters is an early confirmation that WFE orders are rolling over ahead of reported revenue, validating the capex-cut mechanism.
- Forward next-quarter revenue guidance midpoint < 3.2 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $182; 52-week range $82.87–$301; engine rating BUY; house target $250 (+38%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $195 (+7% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
81.6/100 (confidence band 69.7–93.6), 100th percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 91 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | 86 | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 88 | 15% | upside_pct |
| growth | 59 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 100 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 97 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 51 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 74 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 79.0 → 79.0 → 78.7 → 80.6 → 80.6 → 81.6 → 81.8 → 81.8.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — WFE Reset / China Restriction | 20% | $70.00 | -61.4% | -12.3pp |
| Cyclical Downturn — Capex Cut | 17% | $189 | +4.2% | +0.7pp |
| Base — Normalised WFE | 35% | $268 | +47.7% | +16.7pp |
| Upcycle — Leading-Edge / HBM Capex | 20% | $362 | +99.6% | +19.9pp |
| Bull — Supercycle Re-Rate | 8% | $457 | +151.6% | +12.1pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +37.2% |
| Expected return net of SBC dilution | +37.2% |
| Outcome dispersion (σ, from MC p10–p90) | 52.9% |
| Expected Sharpe (rf 4%) | 0.63 |
| Downside expectation (prob-weighted loss branches) | -12.3% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 37.2% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 2.18 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Required return | 13.8% |
| Expected alpha | +23.4% |
| Alpha per unit risk (EA/σ) | +0.44 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 63.2% (1σ) | 44.9% implied | broadly consistent with the market's implied uncertainty |
| Mass above spot: scenarios vs our own MC | 80.0% | 69.2% | the two expressions of our own view agree |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $249.04.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 10 | AI | 99 | |
| Value | 92 | Cloud | 68 | |
| Quality | 87 | Semis | 99 | |
| Momentum | 99 | Consumer | 93 | |
| Low-Vol | 5 | Rates | 85 | |
| USD | 7 | |||
| Energy | 4 |
Portfolio Interaction (Focus Book)
This name is in the top-conviction focus book. Equal-weight book vol 9.8%; diversification benefit 71.5% vs the gross-weighted average single-name vol — combining correlation, the short leg hedging the long leg, and net exposure below 1.0; not diversification alone.
| Interaction | Value |
|---|---|
| Contribution to book risk (component) | 0.69pp |
| Correlation vs SPY | +0.64 |
| Correlation vs QQQ | +0.74 |
| Correlation vs XLK | +0.77 |
| Correlation vs IWM | +0.54 |
| Correlation vs VIXY | -0.49 (VIXY proxies VIX — roll decay) |
| Correlation vs GLD | +0.19 |
| Correlation vs UUP | -0.07 |
Options Intelligence
Preferred structure: Call Debit Spread. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- bullish with cheap options — buy defined-risk upside; a debit spread caps cost vs an outright call
- Direction bullish from the overlay conviction/rating (read-only input).
- IV/RV at the 8th percentile of the cross-section → low vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 92nd percentile of its own month-end history (decile 10). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
- IV term structure is in contango (longer-dated richer, slope +6.8pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.
IV term structure (contango, slope +6.8pp): 32-DTE 57% · 88-DTE 64% · 389-DTE 64%
| Priced structure | Value |
|---|---|
| Legs | Long 182 C, Short 208 C |
| Expiry | 2027-06-17 |
| Max loss | $10.40 |
| Max profit | $15.60 |
| Net debit | $10.40 |
| Return on risk | 150.0% |
| Breakeven | $192 |
Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.
Alternatives: LEAPS, Long Stock. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.50% NAV |
| Maximum position | 0.83% NAV |
| Risk budget | 1.72% NAV |
| Annualized outcome σ (MC) | 52.9% |
| Indicative holding period | 3–12 months |
| Liquidity | high, ~$2,206M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the BUY equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 57.1% (subdued regime) · expected move ±13.3% (2026-09-25) · put/call OI 1.57 · ATM Δ 0.56 / Θ -0.20 / ν 0.21. Direction: LONG (implied return +7.4% to triangulated fair value $194.98).
Bull Call Spread (Bullish) — Long 182 C / Short 208 C · 2027-06-17 · net debit $10.4 · max profit $15.60 · breakeven $192.40 · RoR 150.0% · max loss $10.40 · priced from the listed chain (EOD marks)
Defined-cost leverage to the fair-value gap: the debit is the entire downside, in exchange for participation between the strikes — a way to lean into upside without paying full call premium. Subdued implied volatility currently lowers the premium paid. Illustrative — no outcome is implied or guaranteed.
Long Call (LEAPS) (Bullish) — Long 182 C · 2027-06-17 · premium $43.15 · breakeven $225.15 · max loss $43.15 · priced from the listed chain (EOD marks)
Pure defined-risk directional exposure — the premium is the whole downside while the full upside is retained. A capped, known cost as an alternative to owning the shares outright.
Put Spread (income) (Bullish / income) — Short 165 P / Long 155 P · 2026-10-02 · net $2.5 · net entry $162.50 · yield 1.5% · RoR 33.0% · max loss $7.50 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = BUY because:
- Probability-weighted scenario value implies +37% vs spot
- Monte Carlo median implies +24% vs spot
- DCF fair value implies -21% vs spot — but this is terminal-value sensitive (exit-multiple $144 vs Gordon $76.02, 47% apart), so it carries less weight
- Bear case (Structural — WFE Reset / China Restriction) downside is -61% vs spot
- Net: reward/risk of 0.1× supports a Buy — note this is below 1.0×, i.e. the modelled downside exceeds the modelled upside despite the Buy rating.
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $14B | $8B | $0B | $0B | $7B | $6B |
| FY+2 | $15B | $9B | $0B | $0B | $8B | $6B |
| FY+3 | $16B | $10B | $0B | $0B | $8B | $6B |
| FY+4 | $17B | $10B | $0B | $0B | $9B | $6B |
| FY+5 | $18B | $11B | $1B | $0B | $9B | $6B |
| Terminal | — | — | — | — | $9B × 30.0x | $170B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 10.0% · Σ PV(FCF) $31B + PV(terminal) $170B = EV $201B; − net debt $4.4B → equity $197B ÷ diluted shares $1.37B = $144/share (exit-multiple terminal).
- Gordon terminal at 2.5% → $76.02/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 94% vs WACC 10.0% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| LRCX | 21.6x | 47.6x | 8% | 35% |
| AMAT | 16.1x | 49.3x | 8% | 32% |
| Q | 7.3x | 40.3x | 8% | 23% |
| Median | 16.1x | 47.6x | — | — |
Implied prices at the peer medians: EV/Rev → $151 (no P/E-implied price — no forward-EPS basis at the peer step).
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $144 | 47% | $67.11 |
| Scenario PWEV | $249 | 33% | $83.01 |
| Monte Carlo median | $224 | 20% | $44.86 |
| Triangulated | — | 100% | $195 |
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 10.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 30× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (39.0); Terminal × ±15% (37.0); Op margin ±3pp (15.0); WACC ±1pp (13.0); Capex intensity ±15% (3.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $13.1B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $14.1B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $5.4493 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 1.367B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $1.25B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 10.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 30× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF: WACC 10.0%, terminal multiple 30×, FY+5 revenue $18B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-08-24 |
| MCH engine — trailing 252 adjusted closes | derived | 2026-08-24 | 52-week range (vendor's recorded range was stale and was replaced) | trailing 252 sessions of own close history; config value was stale |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.